Customise Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorised as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyse the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customised advertisements based on the pages you visited previously and to analyse the effectiveness of the ad campaigns.

No cookies to display.

What are the Challenges in Asthma Care and the way forward?

This program is dedicated to the management of asthma and the challenges that clinicians face on a daily basis to provide the best treatment for their patients. We will discuss the latest European guidelines for asthma, the real obstacles that clinicians face, the current game changes in asthma care and see what our future of asthma care will look like. Asthma is a common condition that produces a significant workload for general practice outpatient clinics and inpatient admissions.

Professor Zuzana Diamant, Pulmonologist & clinical pharmacologist in Sweden and Professor at the University of Leuven, Belgium, explains that patients with severe uncontrolled type 2 asthma could be treated with targeted biologics. Professor Diamant believes in the importance of the holistic approach in considering every individual patient in the treatment of asthma.

Professor Leif Bjermer, Professor of allergy and asthma research at the University of Lund, Sweden, discuss the current game changes in the field of asthma care and believes in the introduction of what is called the concept of personalized medicine and the new repertoire treatment in different biologics.

button-block-bgcheckcheckmarkCME badgeCMEcmebadgeCMEdownloadeuforeatveyefacebookfaqglobeicon_1icon_2icon_3Middel 1iconmonstr-facebook-1iconmonstr-info-8iconmonstr-linkedin-1iconmonstr-twitter-1iconmonstr-video-13iconmonstr-youtube-1infographic-blueinfographic-blueinfographic-bulbinfographic-darkblueinforgraphic-yellowinstagramlinkedinpdfpinterestquestionmarksmartphonespotifytweetstwitteryoutube